Substituted 8-perfluoroalkyl-6,7,8,9-tetrahydropyrim ido(1,2-a) pyrimidin-4-one derivatives

Details for Australian Patent Application No. 2004222105 (hide)

Owner Mitsubishi Pharma Corporation Sanofi-Aventis

Inventors Lochead, Alistair; Slowinski, Franck; Saady, Mourad; Yaiche, Philippe

Agent Davies Collison Cave

Pub. Number AU-B-2004222105

PCT Pub. Number WO2004/083210

Priority 03290728.9 21.03.03 EP

Filing date 19 March 2004

Wipo publication date 30 September 2004

Acceptance publication date 4 March 2010

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

29 September 2005 PCT application entered the National Phase

  PCT publication WO2004/083210 Priority application(s): WO2004/083210

4 March 2010 Application Accepted

  Published as AU-B-2004222105

1 July 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004222107-Cationic dimeric dyes

2004222102-Carbon nanostructures and process for the production of carbon-based nanotubes, nanofibres and nanostructures